Clinical Trial

Probiotics in Adults With Rheumatoid Arthritis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 31, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical study is to collect data on the effect of probiotic administration on clinical outcomes in rheumatoid arthritis patients. Participants will: * Have a 6-week daily administration of a probiotic * Collect fecal samples every other day during the first 3 weeks of the study and twice weekly over the last 3 weeks * Visit the clinic at Baseline, Week 3 and Week 6 for checkup and testing
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-12.
Trial Details
NCT Number NCT07304505
Lead Sponsor Ancilia Biosciences
Conditions Rheumatoid Arthritis (RA)
Enrollment 50 participants
Start Date 2025-11-13
Primary Completion 2026-03 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2025-12-31